Share This Article:

HIV-1 Viral Load and CD4 Assessment in HIV-1 Infected Pregnant Women Supported as Part of PMTCT in N’Djamena, Chad

Abstract Full-Text HTML XML Download Download as PDF (Size:446KB) PP. 238-244
DOI: 10.4236/wja.2015.53027    3,667 Downloads   4,021 Views  

ABSTRACT

In Sub-Saharan Africa, HIV affects lots of women of childbearing age; without prevention they can transmit the virus to their child. A cross-sectional study was conducted in the center of Psycho Medico-Social Support (APMS) in N’Djamena, Chad from January 2014 to March 2015. Our sampling concerned HIV-1 infected pregnant women followed up for PMTCT and their newborn. CD4+ lymphocytes and HIV-1 viral load were tested respectively with PIMATM and Abbott m2000 Real Time in mothers. Early infant diagnosis of HIV-1 was done in Children using PCR tool (Abbott m2000 Real Time). Pregnant women included in the study had a median age of 25 years (IQR, 22 - 30 years). Most of them (75.6%) (34/45), were under combination ART (TDF + 3TC or FTC + EFV). The median duration on ART was 4 month (IQR [3 - 5 months]). Nevirapine syrup was administrated to newborns as prophylaxis at least for the first six weeks of life until EID was done. At ART initiation, mothers’ LTCD4+ median was 249 cells/mm3 (IQR: 95 - 674 cells/mm3). After a median duration of 4 months on ART, LTCD4+ median was 530 cells/mm3 (IQR [263 - 1220 cells/mm3]). Viral load assessment in mothers showed that 15.5% (7/45) were undetectable, 75.6% (34/45) were detectable with a VL < 3log copies/ml and 8.8% (4/45) at virologic failure (VL > 3log copies/ ml). Four (11.4%) of 35 children included were tested positive at EID for HIV-1. Antiretroviral treatment management in pregnant women can improve their health and reduce the risk of MTCT. Availability of virologic monitoring in routine is essential for pregnant women in resources limited setting for preventing HIV transmission to their new-born and keep them alive.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Abderrazzack, A. , Salou, M. , Ameyapoh, Y. , Aguid, M. , Hig-Zounet, B. , Chatte, A. and Tidjani, A. (2015) HIV-1 Viral Load and CD4 Assessment in HIV-1 Infected Pregnant Women Supported as Part of PMTCT in N’Djamena, Chad. World Journal of AIDS, 5, 238-244. doi: 10.4236/wja.2015.53027.

References

[1] Alice, D. and Annabel, D.L. (2006) Les femmes africaines face à l’épidémie de sida. Population & Sociétés n° 428, 4.
[2] Kouyoumjian, S.P., Mumtaz, G.R., Hilmi, N., Zidouh, A., El Rhilani, H., et al. (2013) The Epidemiology of HIV Infection in Morocco: Systematicre View and Data Synthesis. International Journal of STD & AIDS, 9, 507-516.
http://dx.doi.org/10.1177/0956462413477971
[3] Peckham, C. and Gibb, D. (1995) Mother to Child Transmission of the Human Immunodeficiency Virus. The New England Journal of Medicine, 4, 298-302. http://dx.doi.org/10.1056/NEJM199508033330507
[4] Connor, E.M., Sperling, R.S., Gelber, R., Kiseley, P., Scott, G., O’Sullivan, M.J., et al. (1994) Reduction of Maternal Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. The New England Journal of Medicine, 7, 1173-1180.
http://dx.doi.org/10.1056/NEJM199411033311801
[5] Renaud, B. and François, D. (2011) Prévention de la transmission mère-enfant du VIH en Afrique Wolters Kluwer France, 15.
[6] Soubeiga, S.T., Compaore, R., Djigma, F., Zagre, N., Assengone, E., Traore, L., et al. (2015) Evaluation du traitement antirétroviral chez les femmes enceintes VIH-1 positif, sur la transmission de l’infection de la mère à l’enfant: Cas du Centre Médical Saint Camille de Ouagadougou, au Burkina Faso. Pan African Medical Journal, 20, 399.
http://www.panafrican-med-journal.com/content/article/20/399/pdf/399.pdf
[7] Dabis, F., Msellati, P., Meda, N., Welffens-Ekra., C., You, B., et al. (1999) 6-Month Efficacy, Tolerance, and Acceptability of a Short Regimen of Oral Zidovudine to Reduce Vertical Transmission of HIV in Breastfed Children in Cote d’Ivoire and Burkina Faso: A Double-Blind Placebo-Controlled Multicentre Trial. DITRAME Study Group. DIminution de la Transmission Mere-Enfant. Lancet, 6,786-792.
[8] Simpore, J., Pietra, V., Pignatelli, S., Karou, D., Nadembega, W.M., Ilboudo, D., et al. (2007) Effective Program against Mother-to-Child Transmission of HIV at Saint Camille Medical Centre in Burkina Faso. Journal of Medical Virology, 6, 873-879. http://dx.doi.org/10.1002/jmv.20913
[9] Pignatelli, S., Simpore, J., Pietra, V., Ouedraogo, L., Conombo, G., Saleri, N., et al. (2006) Factors Predicting Uptake of Voluntary Counselling and Testing in a Real-Life Setting in a Mother-and-Child Center in Ouagadougou, Burkina Faso. Tropical Medicine & International Health, 7, 350-357.
http://dx.doi.org/10.1111/j.1365-3156.2006.01564.x
[10] Sperling, R.S., Shapiro, D.E., Coombs, R.W., Todd, J.A., Herman, S.A., McSherry, G.D., et al. (1996) Maternal Viral load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. The New England Journal of Medicine, 8, 1621-1629. http://dx.doi.org/10.1056/nejm199611283352201
[11] Mandelbrot, L., Landreau-Mascaro, A., Rekacewicz, C., Berrebi, A., Benifla, J.L., Burgard, M., et al. (2001) Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1. JAMA, 10, 2083-2093.
[12] Ioannidis, J.P., Abrams, E.J., Ammann, A., Bulterys, M., Goedert, J.J., Gray, L., et al. (2001) Perinatal Transmission of Human Immunodeficiency Virus Type 1 by Pregnant Women with RNA Virus Loads <1000 Copies/ml. The Journal of Infectious Diseases, 183, 539-545.
http://dx.doi.org/10.1086/318530
[13] Dorenbaum, A., Cunningham, C.K., Gelber, R.D., Culnane, M., Mofenson, L., Britto, P., et al. (2002) Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission: A Randomized Trial. JAMA, 288, 189-198.
http://dx.doi.org/10.1001/jama.288.2.189
[14] European Collaborative Study (2005) Mother-to-Child Transmission of HIV Infection in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases, 7, 458-465.
[15] Achievements in Public Health (2006) Reduction in Perinatal Transmission of HIV Infection—United States, 1985-2005. Morbidity and Mortality Weekly Report, 5, 592-597.
[16] Tubiana, R., Matheron, S., Le Chenadec, J., Dollfus, C., Faye, A., Blanche, S., et al. (2011) Extremely Low Risk of Mother-to-Child Transmission of HIV in Women Starting HAART before Pregnancy in the French Perinatal Cohort (ANRS EPF CO1/11). CROI 2011.
[17] OMS (2006) Ampleur de la pandémie du VIH et SIDA. Prévention de la Transmission du VIH de la Mère à l’Enfant, Matériel Générique de Formation, Module 1, Module du Formateur. Organisation mondiale de la Santé, 4.
[18] OMS (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach.
http://www.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf
[19] CNLS (2013) Rapport sérosurveillance sentinelle du VIH chez les femmes enceintes pour l’année. Conseil National de Lutte Contre le Sida, 17, 7-28.
[20] Ministère de la sante publique (2012) Plan national d’élimination de la transmission du VIH de la mère à l’enfant au Tchad 2012-2015. Vol. 63, 12, 5-17.
[21] CNLS (2012) Rapport annuel sur le VIH au Tchad. Conseil National de Lutte Contre Le Sida, 9, 11-20.
[22] OMS (2005) La transmission du VIH par l’allaitement au sein: Bilan des connaissances actuelles.
http://whqlibdoc.who.int/publications/2005/9242562718_fre.pdf
[23] Rosalind, J., Kate, D., Wafaa, M.E., Landon, M., Juliana, O., et al. (2010) CD4+ Cell Count Testing More Effective Than HIV Disease Clinical Staging in Identifying Pregnant and Postpartum Women Eligible for Antiretroviral Therapy in Resource-Limited Settings. JAID, 5, 404-410.
[24] Ruth, E.T., Heather, D.W., Li, D., Mark, V., Jane, P., Hunter, H., et al. (2005) Improved Obstetric Outcomes and Few Maternal Toxicities Are Associated With Antiretroviral Therapy Including Highly Active Antiretroviral Therapy During Pregnancy. JAID, 38, 449-473.
[25] Hocini, H. and Andreoletti, L. (2009) Méthodes d’analyse et de suivi de l’infection par les virus de l’immunodéficience humaine. Revue Francophone Des Laboratoires, 2009, 39-48.
http://dx.doi.org/10.1016/S1773-035X(09)70308-9
[26] Eholié, S.P., Bennaï, Y., Courpotin, C., Ekouevi, D. and Raguin, G. (2009) Mémento thérapeutique du VIH/SIDA en Afrique 1, 70-71.
[27] Marie, L.N., Hoosen, C., Marjo, C.B., Nigel, R., Philippe, G. and Francois, D. (2004) Mortality of Infected and Uninfected Infants Born to HIV-Infected Mothers in Africa: A Pooled Analysis. Elsevier, 7, 1236-1243.
[28] Becquet, R., Bland, R.M., Ekouevi, D.K., Dabis, F. and Newell, M.L. (2010) Universal Antiretroviral Therapy among Pregnant and Postpartum HIV-Infected Women Would Improve Maternal Health and Decrease Postnatal HIV Transmission. AIDS, 24, 1239-1241.
http://dx.doi.org/10.1097/QAD.0b013e328338b791
[29] Tang, J. and Nour, N.M. (2010) HIV and Pregnancy in Resource-Poor Settings. Reviews in Obstetrics and Gynecology, 5, 66-71.
[30] Kourtis, A.P., Bulterys, M., Nesheim, S.R. and Lee, F.K. (2001) Understanding the Timing of HIV Transmission from Mother to Infant. JAMA, 285, 709-712.
[31] Becquet, R. (2007) Antiretroviral Therapy among HIV-Infected Breastfeeding Mothers: A Promising Strategy to Prevent HIV Transmission through Breastmilk in Africa. Future HIV Therapy, 1, 17-21.
http://dx.doi.org/10.2217/17469600.1.1.17
[32] Becquet, R., Bland, R., Leroy, V., Rollins, N.C., Ekouevi, D.K., Coutsoudis, A., et al. (2009) Duration, Pattern of Breastfeeding and Postnatal Transmission of HIV: Pooled Analysis of Individual Data from West and South African Cohorts. PLoS ONE, 4, e7397-e7401.
http://dx.doi.org/10.1371/journal.pone.0007397
[33] Shapiro, R.L., Ndung'u, T., Lockman, S., Smeaton, L.M., Thior, I., et al. (2005) Highly Active Antiretroviral Therapy Started during Pregnancy or Postpartum Suppresses HIV-1 RNA, but Not DNA, in Breast Milk. The Journal of Infectious Diseases, 192, 713-719.
http://dx.doi.org/10.1086/432489
[34] Monalisa, T.M., Junior, M., Ingrid, A.B., Lisa, M.F., Mqondisi, T., Justen, M., et al. (2015) The Burden of HIV Associated Drug Resistance Mutations in an Early Infant Diagnosis Program: A Glance through the Paediatric Window of Zimbabwe. Journal of Infectious Diseases and Therapeutics, 3, 198.
[35] Diack, M.A., Signate, S., Diagne Gueye, N.R., Ba, A., Sylla, A., Diouf, S., et al. (2005) Aspects epidemiologiques et cliniques de l’infection à VIH de l'enfant au centre hospitalier national d'enfants Albert-Royer à Dakar. Archives de Pédiatrie, 12, 404-409.
http://dx.doi.org/10.1016/j.arcped.2005.01.011
[36] Mouffok, N., Errouane, K., Khellifi, M.L., Tahrour, M., Razik, F., et al. (2008) Le profil clinique et evolutif de l’infection à VIH chez l’enfant à l’ouest algerien. Médecine et Maladies Infectieuses, 38, S170-S172.
http://dx.doi.org/10.1016/S0399-077X(08)73188-3
[37] d’Almeida, M., Sagbo, G., Lalya, F., Alao, M.J., d’Almeida, C., Agossou, J., et al. (2013) Profile of HIV-Infected Children at the University Hospital CNHU of Cotonou. CNHU, Cotonou, 6.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.